References
- World Health Organization. Steroid contraception and the risk of neoplasia. Technical Report Series No. 619, Geneva 1978
- Kalache A, McPherson K, Barltrop K, Vessey M. Oral contraceptives and breast cancer. Brit J Hospital Med 1983; 30: 278–83
- Pike M C., Henderson B E., Krailo M D., Duke A, Roy S. Breast cancer in young women and use of oral contraceptives: possible modifying effect of formulation and age at use. Lancet 1983; ii: 926–30
- Pike M C., Henderson B E., Casagrande J T., Rosario I, Gray G E. Oral contraceptive use and early abortion as risk factors for breast cancer in young women. Br J Cancer 1981; 43: 72–6
- Mishell D R. Oral steroids. Reproductive endocrinology, infertility and contraception, D R. Mishell, V Dajavan. FA Davis, Philadelphia 1979; 487–523
- McPherson K, Neil A, Vessey M P., Doll R. Oral contraceptives and breast cancer. Lancet 1983; ii: 1414–5
- Le M G., Bachelot A, Doyon F, Kramar A, Hill C. Oral contraceptive use and breast cancer or cervical cancer: Preliminary results of a French case-control study. Hormones and sexual factors in human cancer aetiology, J P. Wolff, J S. Scott. Elsevier Science Publisher. 1984; 139–47
- Olsson H, Olsson Landin M., Möller T R., Ranstam J, Holm P. Oral contraceptive use and breast cancer in young women in Sweden. Lancet 1985; i: 748–9
- Stadel B V., Rubin G L., Webster L A., Schlesselman J J., Wingo P A. Oral contraceptives and breast cancer in young women. Lancet 1985; ii: 970–3
- Swyer G IW. Progestogen potency and breast cancer. Lancet 1983; ii: 1416
- Meirik O, Arvidsson A, Springfeldt P. Use of oral contraceptives in Sweden. In: National Board of Health and Welfare. Drug Information Committee: Hormonal Contraception 1984; 3: 1–10